CryptoProwl
Tue, June 2, 2026 astatine 9:49 AM CDT 1 min read
Canada’s HIVE Digital Technologies (NASDAQ: $HIVE) has reported a 158% surge successful its gross arsenic it pivots from Bitcoin (CRYPTO: $BTC) miner to artificial quality (A.I.) information centre operator.
The institution has reported full gross of $297.8 cardinal U.S. for its fiscal twelvemonth ended March 31, up 158% from the twelvemonth earlier period.
Revenue from HIVE’s integer currency soared 164% year-over-year to $278.3 cardinal U.S., driven by a four-fold summation successful its installed operational hashrate.
More From Cryptoprowl:
-
Ripple, The Company Behind XRP, Is Valued At $50 Billion
-
Eightco Secures $125 Million Investment From Bitmine And ARK Invest, Shares Surge
-
Blockchain Projects Decline 75% As Developers Shift To A.I.
-
Stanley Druckenmiller Says Stablecoins Could Reshape Global Finance
-
New York Stock Exchange Invests $600 Million In Polymarket
HIVE said that it mined 2,885 Bitcoin during the fiscal year, up 104% from 2025, contempt an approximate 42% summation successful web difficulty.
The company’s high-performance computing hosting work concern generated the remaining $19.5 cardinal U.S. successful gross for the fiscal year, a grounds for the institution and up 94% from $10 cardinal U.S. successful 2025.
HIVE remains unprofitable and the steadfast reported a nett nonaccomplishment of $148.4 cardinal U.S. for the conscionable completed fiscal year, mostly owed to unrealized losses connected its investments.
Management astatine HIVE said that their Bitcoin holdings proceed to diminution arsenic the institution focuses much connected A.I. information centres and high-performance computing.
HIVE reduced its Bitcoin holdings by 331 BTC during the astir caller quarter. The company’s full holdings present basal astatine 150 Bitcoin, down from 481 BTC astatine the extremity of 2025.
HIVE reported $10.8 cardinal U.S. successful full integer plus holdings arsenic of March 31, including the 150 BTC presently connected its equilibrium sheet.
HIVE banal has risen 167% this twelvemonth to commercialized astatine $4.72 U.S. per share.

1 hour ago
2




.png)
English (CA) ·
English (US) ·
Spanish (MX) ·